INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
137 hedge funds and large institutions have $556M invested in Infinity Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 59 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
20% less capital invested
Capital invested by funds: $691M → $556M (-$135M)
Holders
137
Holding in Top 10
–
Calls
$3.56M
Puts
$3.07M
Top Buyers
| 1 | +$20.9M | |
| 2 | +$9.92M | |
| 3 | +$6.94M | |
| 4 |
Renaissance Technologies
New York
|
+$5.81M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5.21M |
Top Sellers
| 1 | -$16.5M | |
| 2 | -$12.2M | |
| 3 | -$7.43M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$6.13M |
| 5 |
Millennium Management
New York
|
-$4.76M |